Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol

BACKGROUND: Recent studies demonstrated the efficacy of S-1-based adjuvant chemotherapy administered for six months after curative surgery for stage III gastric cancer; however, it is unproven whether this type of combination chemotherapy is more effective than the standard adjuvant chemotherapy of...

Descripción completa

Detalles Bibliográficos
Autores principales: Namikawa, Tsutomu, Maeda, Hiromichi, Kitagawa, Hiroyuki, Oba, Koji, Tsuji, Akihito, Yoshikawa, Takaki, Kobayashi, Michiya, Hanazaki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812232/
https://www.ncbi.nlm.nih.gov/pubmed/29439671
http://dx.doi.org/10.1186/s12885-018-4109-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812232/
https://www.ncbi.nlm.nih.gov/pubmed/29439671
http://dx.doi.org/10.1186/s12885-018-4109-z

Ejemplares similares